Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Frontage Labs Completes Acquisition of Teddy Lab | Contract Pharma

What are you searching for?

Sign in
Breaking News

Frontage Labs Completes Acquisition of Teddy Lab

Aims to enhance Frontage's global lab service capabilities and strengthen its presence in China and the Asia-Pac region.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma
Frontage Labs

Frontage Laboratories, Inc., a global CRO/CDMO, completed the acquisition of Teddy Clinical Research Laboratory (Shanghai), Ltd. (Teddy Lab), a clinical research laboratory service provider in China. The acquisition aims to enhance Frontage’s global laboratory service capabilities and further strengthen its presence in China and the Asia-Pacific region.

Teddy Lab has extensive experience supporting more than 1,500 clinical trials across multiple therapeutic areas. The company is known for its GCP-compliant operations and internationally accredited laboratory services. Teddy Lab operates under CAP-accredited and NGSP Level 1 certified quality systems, as well as qualification as a Class II Unsealed Radioactive Material Workplace. Its track record includes supporting regulatory inspections and contributing to the successful marketing approval of 50 new drugs.

As a result of the transaction, Frontage has expanded its central laboratory footprint in China, which it expects to leverage in supporting the increasing demand for both domestic China and multi-regional clinical trials (MRCT). 

The acquisition further supports our role as a “one-stop shop” in delivering high-quality drug development services to pharmaceutical companies, biotechnology firms, contract research organizations, and research institutions worldwide. We anticipate that our continued investment in expanding our global infrastructure and scientific capabilities will help us meet the evolving needs of the life sciences industry.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics